comparemela.com

Latest Breaking News On - Haffkine biopharma - Page 5 : comparemela.com

Haffkine Biopharma to manufacture around 22 8 million doses of Covaxin vaccination per year

Will take 1 year to roll out vaccine: Haffkine | India News

NEW DELHI: Haffkine Biopharma will take at least a year to roll out Covaxin, although the Centre has given it an expected timeline of six months. Constructing the facility alone could take six months, followed by validation steps and multiple quality checks. The firm’s MD Sandeep Rathod said they will try to expedite the process FacebookTwitterLinkedinEMail

Govt moves to step-up Covaxin production - The Hindu BusinessLine

Govt moves to step-up Covaxin production April 16, 2021 × Ropes in 3 govt units, funds upgrade of Bharat Bio facility to raise monthly output to 10 cr doses by Sept The Government has unveiled a plan to expand the manufacture of indigenous vaccine, Covaxin. The aim is to make 10 crore doses a month, by September. The plan involves upgrading Hyderabad-based Bharat Biotech Ltd, which produces Covaxin, besides building-up the production capacities of public sector manufacturers Haffkine Biopharmaceutical Corp, Indian Immunologicals Ltd, and Bharat Immunologicals & Biologicals Corporation with infrastructure and technology. The current production capacity will be doubled by May-June and then increased 6-7 fold by July-August. Thta is, production will be stepped up from 1 crore doses in April to 6-7 crore vials per month in July-August. It is likely to reach nearly 10 crore doses per month by September under the government’s Mission Covid Suraksha, the Health Ministry said

State wants Haffkine to produce Covaxin

State wants Haffkine to produce Covaxin ByYogesh NaikYogesh Naik / Updated: Feb 21, 2021, 07:05 IST The Maharashtra medical education department has written to the Centre and the Indian Council of Medical Research ( ICMR) to allow the state- owned Haffkine Bio-Pharmaceutical Corporation Limited to manufacture Covaxin, which is currently being manufactured by Bharat Biotech. State medical education departments secretary Saurabh Vijay said, “We have written to the central government to allow us transfer of technology so that Covaxin can be manufactured in Haffkine’s plants in Mumbai and other places. If they give us aid and transfer of technology, then we can upgrade our plants and start production in six months, and it will add to total capacity. We are awaiting a response from the Centre.’’

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.